Cargando…

216. Association Between Days to Initiate Appropriate Therapy and Hospital Length of Stay Among Adult Hospitalized Patients With Gram-negative Bloodstream Infections (GN-BSI)

BACKGROUND: The deleterious outcomes associated with delay receipt of appropriate therapy are well documented. However, scant data exists on the consequences of each day delay of appropriate therapy and subsequent outcomes among adult hospitalized patients with GN-BSIs. METHODS: Study design: a retr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lodise, Thomas, Kanakamedala, Hemanth, Hsu, Wei-Chun, Cai, Bin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2019
Materias:	Abstracts
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6810357/ http://dx.doi.org/10.1093/ofid/ofz360.291

Ejemplares similares

164. Analysis of Adult, Hospitalized Patients With Carbapenem-resistant (CR) Gram-Negative Bloodstream Infections (GN-BSIs) due to Lactose Fermenters (LFs) and Non-lactose Fermenters (NLFs): Is There a Difference in Outcomes?
por: Lodise, Thomas, et al.
Publicado: (2019)

2163. Risk Factors for Carbapenem-Resistant Gram-Negative Bloodstream Infections (BSI) in U.S. Hospitals (2010–2015)
por: Cai, Bin, et al.
Publicado: (2018)

1187. Evaluation of an Antimicrobial Stewardship (AS) Bundle for Uncomplicated Gram-Negative Bloodstream Infections (GN-BSI) in Adults at a Large Academic Health System
por: Dipietro, Juliana M, et al.
Publicado: (2023)

Changing Trends in Antimicrobial Susceptibility Patterns of Bloodstream Infection (BSI) in Secondary Care Hospitals of India
por: Karuna, T, et al.
Publicado: (2023)

Estimating length of stay and inpatient charges attributable to hospital-acquired bloodstream infections
por: Zhang, Yuzheng, et al.
Publicado: (2020)

P39 Bloodstream infections (BSI) in tertiary ICU—an update!
por: Patel, Veer M., et al.
Publicado: (2022)

Burden of illness in US hospitals due to carbapenem-resistant Gram-negative urinary tract infections in patients with or without bacteraemia
por: Shields, Ryan K., et al.
Publicado: (2021)

Delays in Appropriate Antibiotic Therapy for Gram-Negative Bloodstream Infections: A Multicenter, Community Hospital Study
por: Moehring, Rebekah W., et al.
Publicado: (2013)

A 21-Year Survey of Escherichia coli from Bloodstream Infections (BSI) in a Tertiary Hospital Reveals How Community-Hospital Dynamics of B2 Phylogroup Clones Influence Local BSI Rates
por: Rodríguez, Irene, et al.
Publicado: (2021)

The relationship between minimum inhibitory concentration and 28 day mortality in patients with a Gram-negative bloodstream infection: an analysis of data from a cohort study (BSI-FOO)
por: Evans, Rebecca N, et al.
Publicado: (2023)

Achievements of BSI hospital-wide surveillance in Belgium
por: Morales, I, et al.
Publicado: (2011)

1458. Burden of Illness in Patients with Urinary Tract Infections With or Without Bacteremia Caused by Carbapenem-Resistant Gram-Negative Pathogens in US Hospitals (2014 to 2018)
por: Shields, Ryan K, et al.
Publicado: (2019)

Impact of bloodstream infections caused by carbapenem-resistant Gram-negative pathogens on ICU costs, mortality and length of stay
por: Kousouli, E., et al.
Publicado: (2019)

Costs and Extra Length of Stay because of Neonatal Bloodstream Infection at a Teaching Hospital in Ghana
por: Fenny, Ama Pokuaa, et al.
Publicado: (2020)

1191. Prevalence and Microbiology of Carbapenem Resistance Among Six Gram-Negative Pathogens in Bloodstream Infections in US Hospitals, 2010–2015
por: Lodise, Thomas P, et al.
Publicado: (2018)

Excess Length of Acute Inpatient Stay Attributable to Acquisition of Hospital-Onset Gram-Negative Bloodstream Infection with and without Antibiotic Resistance: A Multistate Model Analysis
por: Suzuki, Hiroyuki, et al.
Publicado: (2020)

1485. Trends in Important-Resistant Gram-Negative (GN) and Gram-Positive (GP) Urine Bacterial Pathogens in Hospitalized Patients in the United States: A Multicenter Evaluation from 2013 to 2018
por: Lodise, Thomas, et al.
Publicado: (2019)

1005. HIV-Associated Bloodstream Infection (BSI): Trends Over 7 Years
por: Hooshmand, Babak, et al.
Publicado: (2018)

38. Predicting stenotrophomonas Maltophilia bloodstream Infections (BSI) in the Hematologic Malignancy Population
por: Karaba, Sara M, et al.
Publicado: (2020)

Appropriateness of Acute Medical Admissions and Length of Stay
por: Smith, Helen E, et al.
Publicado: (1997)

A targeted methicillin-resistant Staphylococcus aureus (MRSA) control program did not affect total nosocomial Staphylococcus aureus (SA) bloodstream infections (BSI) despite reducing MRSA BSI
por: Amri, B, et al.
Publicado: (2011)

855 Risk Factors for Peripherally Inserted Central Catheter (PICC) Bloodstream Infection (BSI)
por: Kagan, Evgenia, et al.
Publicado: (2014)

1643. Pharmacodynamics (PD) of Daptomycin (DAP) in Combination Therapy for Enterococcal Bloodstream Infection (BSI)
por: Avery, Lindsay, et al.
Publicado: (2018)

14-Year Survey in a Swedish County Reveals a Pronounced Increase in Bloodstream Infections (BSI). Comorbidity - An Independent Risk Factor for Both BSI and Mortality
por: Holmbom, Martin, et al.
Publicado: (2016)

1041. How Do Healthcare Providers Approach Empiric β-Lactam (BL) Treatment of Bloodstream Infections (BSI) Caused by Gram-Negative Rods (GNRs)? Analysis of Escherichia coli and Klebsiella pneumoniae BSI From the Veterans Health Administration (VHA)
por: Viau, Roberto, et al.
Publicado: (2018)

Dalbavancin Efficacy and Impact on Hospital Length-of-Stay and Treatment Costs in Different Gram-Positive Bacterial Infections
por: Poliseno, Mariacristina, et al.
Publicado: (2021)

Length of Stay in Patients With Central Line-Associated Bloodstream Infection at a Tertiary Hospital in the Kingdom of Saudi Arabia
por: Alotaibi, Naif H, et al.
Publicado: (2020)

The increased risks of death and extra lengths of hospital and ICU stay from hospital-acquired bloodstream infections: a case–control study
por: Barnett, Adrian G, et al.
Publicado: (2013)

Does clinical governance influence the appropriateness of hospital stay?
por: Specchia, Maria Lucia, et al.
Publicado: (2015)

The increasing impact of length of stay “outliers” on length of stay at an urban academic hospital
por: Hughes, Andrew H., et al.
Publicado: (2021)

Healthcare-associated (HA) bloodstream infections (BSI) secondary top surgical site infections: surveillance program across Quebec hospitals (2007 to 2010)
por: Blouin, V, et al.
Publicado: (2011)

Protein Intake at the First Day of Full‐Oral Intake During Hospitalization Is Associated With Complications and Hospital Length of Stay
por: Dijxhoorn, Dorian N., et al.
Publicado: (2020)

912. Impact of Rapid Identification and Stewardship Intervention on Coagulase-negative Staphylococcus Bloodstream Infection (BSI)
por: Goshorn, Eli S, et al.
Publicado: (2022)

An institutional perspective on the impact of recent antibiotic exposure on length of stay and hospital costs for patients with gram-negative sepsis
por: Micek, Scott, et al.
Publicado: (2012)

Emergency medical admissions and COVID-19: impact on 30-day mortality and hospital length of stay
por: Conway, Richard P., et al.
Publicado: (2021)

Direct costs associated with the appropriateness of hospital stay in elderly population
por: Mould-Quevedo, Joaquín F, et al.
Publicado: (2009)

Combination Vancomycin/Cefazolin (VAN/CFZ) for Methicillin-Resistant Staphylococcus aureus (MRSA) Bloodstream Infections (BSI)
por: Trinh, Trang D, et al.
Publicado: (2017)

171. Rising Rates of Gram-Negative Bacilli Blood Stream (GNB-BSI) Infection in Adults
por: Johnson, Leonard B, et al.
Publicado: (2019)

90. Impact of Discrepant Rapid Diagnostic Test (RDT) Results on Antimicrobial Stewardship Program (ASP) Interventions in Patients with Bloodstream Infections (BSI) due to Gram-Negative Bacilli (GNB)
por: Robinson, Evan D, et al.
Publicado: (2020)

Benchmarking and reducing length of stay in Dutch hospitals
por: Borghans, Ine, et al.
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_1lf175h20sr1du5g3hd4h87gni